Chemoinformaics analysis of MONTANIC-ACID-MONOGLYCERIDE
| Molecular Weight | 320.298 | nRot | 10 |
| Heavy Atom Molecular Weight | 300.138 | nRig | 7 |
| Exact Molecular Weight | 320.122 | nRing | 1 |
| Solubility: LogS | -0.9 | nHRing | 1 |
| Solubility: LogP | -3.28 | No. of Aliphatic Rings | 1 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 41.9919 |
| nHD | 6 | BPOL | 24.9481 |
| QED | 0.22 |
| Synth | 4.007 |
| Natural Product Likeliness | -0.124 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.312 |
| HIA | 0.927 |
| CACO-2 | -6.261 |
| MDCK | 0.00475128 |
| BBB | 0.397 |
| PPB | 0.185798 |
| VDSS | 0.442 |
| FU | 0.895307 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.285 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.154 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.001 |
| CL | 1.502 |
| T12 | 0.92 |
| hERG | 0.009 |
| Ames | 0.016 |
| ROA | 0.003 |
| SkinSen | 0.235 |
| Carcinogencity | 0.026 |
| EI | 0.009 |
| Respiratory | 0.166 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.833408 |